Lv2
120 积分 2025-07-12 加入
Antibody-drug conjugates in gynaecological cancers: opportunities and challenges
10天前
已完结
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
11天前
已完结
Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer
16天前
已完结
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance
1个月前
已完结
Clinical and translational advances in ovarian cancer therapy
1个月前
已完结
Global epidemiology of epithelial ovarian cancer
1个月前
已完结
Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers
11个月前
已完结
皖公网安备34019202002308
